Artificial intelligence is increasingly establishing itself in the pharmaceutical industry. Research into new or optimizable active ingredients for drug production and disease control is an essential area in the industry. The combination of the permanently growing number of possible active ingredient candidates simultaneously requires a huge amount of data. In order to keep track of this number and derive the right conclusions, artificial intelligence is increasingly being called upon to provide information about the most important changes and developments. Artificial intelligence also helps to include all available data, since according to recent studies, 80 percent of medical data is not used after it has been collected.
Read our new arcoro CONNECT to learn more about mergers between different pharmaceutical and IT companies and how AI can efficiently support drug discovery.